Robert J. Glynn

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Paul M. Ridker, Brendan M. Everett, Aruna D. Pradhan et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

Paul M. Ridker, Samuel Z. Goldhaber, Ellie Danielson et al. · New England Journal of Medicine · 2003 · 809 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart et al. · New England Journal of Medicine · 2022 · 711 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16